Osamu Ohmori

3.0k total citations
83 papers, 2.4k citations indexed

About

Osamu Ohmori is a scholar working on Molecular Biology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Osamu Ohmori has authored 83 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Psychiatry and Mental health and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Osamu Ohmori's work include Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (12 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Osamu Ohmori is often cited by papers focused on Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (12 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Osamu Ohmori collaborates with scholars based in Japan, Canada and United States. Osamu Ohmori's co-authors include Makoto Fujita, Masaki Kawano, Takahiro Shinkai, Jun Nakamura, Hiroko Hori, Takeshi Terao, Hideki Kojima, Kazuhiko Abe, Chima Matsumoto and Dowdy Jackson and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Osamu Ohmori

83 papers receiving 2.3k citations

Peers

Osamu Ohmori
Michael Honer Switzerland
Sajinder K. Luthra United Kingdom
Simon M. Ametamey Switzerland
Neil Vasdev United States
Linjing Mu Switzerland
William L. Neumann United States
Osamu Ohmori
Citations per year, relative to Osamu Ohmori Osamu Ohmori (= 1×) peers Michael J. Adam

Countries citing papers authored by Osamu Ohmori

Since Specialization
Citations

This map shows the geographic impact of Osamu Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Ohmori more than expected).

Fields of papers citing papers by Osamu Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Ohmori. The network helps show where Osamu Ohmori may publish in the future.

Co-authorship network of co-authors of Osamu Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Ohmori. A scholar is included among the top collaborators of Osamu Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Ohmori. Osamu Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utsunomiya, Kensuke, Takahiro Shinkai, Shinichi Sakata, et al.. (2010). Lack of Association Between the Leptin Receptor Gene (LEPR) Gln223Arg Polymorphism and Late-onset Alzheimer Disease. Alzheimer Disease & Associated Disorders. 24(1). 101–103. 6 indexed citations
2.
Sakurama, Kazufumi, Kazuhiro Noma, Munenori Takaoka, et al.. (2009). Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 8(1). 127–134. 58 indexed citations
3.
Watanabe, Nobuyuki, Munenori Takaoka, Kazufumi Sakurama, et al.. (2008). Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo. Clinical Cancer Research. 14(14). 4631–4639. 46 indexed citations
4.
Shinkai, Takahiro, Vincenzo De Luca, Kensuke Utsunomiya, et al.. (2008). Functional Polymorphism of the Human Multidrug Resistance Gene (MDR1) and Polydipsia–Hyponatremia in Schizophrenia. NeuroMolecular Medicine. 10(4). 362–367. 19 indexed citations
5.
Shinkai, Takahiro, Vincenzo De Luca, Rudi Hwang, et al.. (2007). Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia. NeuroMolecular Medicine. 9(2). 169–177. 38 indexed citations
6.
Shi, Qing, Anita B. Hjelmeland, Stephen T. Keir, et al.. (2007). A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Molecular Carcinogenesis. 46(6). 488–496. 159 indexed citations
7.
Hori, Hiroko, Takahiro Shinkai, Chima Matsumoto, Osamu Ohmori, & Jun Nakamura. (2006). No Association Between a Functional NAD(P)H: Quinone Oxidoreductase Gene Polymorphism (Pro187Ser) and Tardive Dyskinesia. NeuroMolecular Medicine. 8(3). 375–380. 8 indexed citations
8.
Yoshimura, Reiji, Koji Shinkai, Makiko Goto, et al.. (2005). Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6. International Clinical Psychopharmacology. 20(2). 71–78. 80 indexed citations
9.
Shinkai, Takahiro, Vincenzo De Luca, Rudi Hwang, et al.. (2005). Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia. Neuroscience Letters. 388(2). 116–120. 14 indexed citations
10.
Shinkai, Takahiro, Vincenzo De Luca, Gwyneth Zai, et al.. (2004). No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia. Psychiatric Genetics. 14(3). 177–180. 14 indexed citations
11.
Ohmori, Osamu, Takahiro Shinkai, Hiroko Hori, Chima Matsumoto, & Jun Nakamura. (2003). A perspective on molecular genetic studies of tardive dyskinesia: one clue for individualized antipsychotic drug therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(4). 581–586. 15 indexed citations
12.
Ohmori, Osamu, Takahiro Shinkai, Hiroko Hori, & Jun Nakamura. (2002). Genetic association analysis of 5-HT6 receptor gene polymorphism (267C/T) with tardive dyskinesia. Psychiatry Research. 110(2). 97–102. 23 indexed citations
13.
Shinkai, Takahiro, Osamu Ohmori, Hiroko Hori, & Jun Nakamura. (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Molecular Psychiatry. 7(6). 560–563. 91 indexed citations
14.
Matsumoto, Chima, Osamu Ohmori, Hiroko Hori, Takahiro Shinkai, & Jun Nakamura. (2002). Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans. Neuroscience Letters. 321(3). 165–168. 12 indexed citations
15.
Ohmori, Osamu, et al.. (2001). Novel polymorphism in the 5′-upstream region of the human 5-HT6 receptor gene and schizophrenia. Neuroscience Letters. 310(1). 17–20. 14 indexed citations
16.
Ohmori, Osamu, et al.. (2000). Synapsin III gene polymorphisms and schizophrenia. Neuroscience Letters. 279(2). 125–127. 22 indexed citations
17.
Terao, Takeshi, Hideki Nakano, Takahiro Shinkai, et al.. (1999). A Simpler and More Accurate Equation toPredict Daily Lithium Dose. Journal of Clinical Psychopharmacology. 19(4). 336–340. 12 indexed citations
18.
Shinkai, Takahiro, Osamu Ohmori, Hideki Kojima, et al.. (1998). Negative Association between T102C Polymorphism of the 5-HT<sub>2a</sub> Receptor Gene and Schizophrenia in Japan. Human Heredity. 48(4). 212–215. 33 indexed citations
19.
Ono, Takao, Yukiko Fueta, Najma A. Janjua, et al.. (1997). Granule cell disinhibition in dentate gyrus of genetically seizure susceptible El mice. Brain Research. 745(1-2). 165–172. 13 indexed citations
20.
Ohmori, Osamu, Hideyasu Hirano, Takao Ono, Kazuhiko Abe, & Takashi Mita. (1996). Down-regulation of S-adenosylhomocysteine hydrolase in the active methyl transfer system in the brain of genetically epileptic El mice. Neurochemical Research. 21(10). 1173–1180. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026